1. Home
  2. AUR vs CYTK Comparison

AUR vs CYTK Comparison

Compare AUR & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Innovation Inc.

AUR

Aurora Innovation Inc.

HOLD

Current Price

$6.31

Market Cap

12.5B

Sector

Technology

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$77.27

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUR
CYTK
Founded
2017
1997
Country
United States
United States
Employees
N/A
673
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
10.7B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
AUR
CYTK
Price
$6.31
$77.27
Analyst Decision
Buy
Strong Buy
Analyst Count
4
19
Target Price
$9.43
$89.26
AVG Volume (30 Days)
27.8M
1.8M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
4.35
N/A
EPS
N/A
N/A
Revenue
$3,000,000.00
$13,368,000.00
Revenue This Year
$407.30
$7.37
Revenue Next Year
$1,134.58
$310.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$35.22
52 Week High
$8.57
$88.31

Technical Indicators

Market Signals
Indicator
AUR
CYTK
Relative Strength Index (RSI) 44.55 48.34
Support Level $5.78 $73.34
Resistance Level $6.75 $79.66
Average True Range (ATR) 0.35 2.63
MACD -0.08 0.06
Stochastic Oscillator 24.06 49.86

Price Performance

Historical Comparison
AUR
CYTK

About AUR Aurora Innovation Inc.

Aurora Innovation is a US autonomous driving provider for heavy trucks. The company produces and sells its Aurora Driver system, which includes hardware installed in a vehicle, software to autonomously drive it, and data management to maintain and improve the software. Aurora targets long-haul routes. The company currently offers its trucking-as-a-service model, where it owns and operates the trucks and makes deliveries for customers. The company plans to start selling its driver-as-a-service model next year, where fleet owners will own the trucks and Aurora's software will operate them.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: